JNJ · Johnson & Johnson · Debt
$270.56
-2.64 (-0.97%)
At close · Nov 2
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$657.68B
Shares
2.41B
Volume · Nov 2
8.3M
Avg daily vol (3M)
6.92M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Latest reported total
USD 49,000,000,000
As of Jun 28, 2026
Tracked instruments
0
Loans, facilities and note series
Annual baseline
—
Latest approved annual total
Reported total debt history
| As of | Reported label | Amount | Source |
|---|---|---|---|
| 2026-06-28 | The Company's debt position | USD 49,000,000,000 |
10-Q filed 2026-07-23
The Company's debt position was $49.0 billion as of June 28, 2026, as compared to $50.8 billion the same period a year ago. |
| 2026-03-29 | notes payable and long-term debt | USD 55,000,000,000 |
10-Q filed 2026-04-22
As of March 29, 2026, the Company had cash, cash equivalents and marketable securities of approximately $22.1 billion and had approximately $55.0 billion of notes payable and long-term debt for a net debt position of $32.9 billion as compared to the prior year fiscal first quarter net debt position of $13.5 billion. |
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Noncurrent debt carrying amount | 2026-06-28 | USD 37,344,000,000 | 10-Q filed 2026-07-23 |
| Short-term borrowings | 2026-06-28 | USD 11,692,000,000 | 10-Q filed 2026-07-23 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
2 filings have incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
200406
CUSIP
478160104
13F (30d)
2453 filings
2347 filers
Visit website
Investor relations